Feedback

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Affiliation
Tokyo Metropolitan Institute for Geriatrics and Gerontology Tokyo Japan
Toyohara, Jun;
Affiliation
University of Groningen Groningen The Netherlands
Elsinga, Philipp H.;
Affiliation
University of Milano-Bicocca Monza Italy
Todde, Sergio;
Affiliation
Turku PET Centre University of Turku Turku Finland
Li, Xiang-Guo;
Affiliation
IRCCS SDN SynLab Naples Italy
Aime, Silvio;
Affiliation
University of Groningen Groningen The Netherlands
Szymanski, Wictor C.;
Affiliation
Paul Scherrer Institute Villigen Switzerland
van der Meulen, Nick;
Affiliation
Katholieke Universiteit Leuven Belgium
Cleeren, Frederik;
Affiliation
Medical Isotope and Cyclotron Facility, Affiliated member Chemistry and Pharmacy University of Alberta, Cross Cancer Institute, University of Alberta Edmonton AB Canada
Schirrmacher, Ralf;
Affiliation
TRIUMF Vancouver BC Canada
Yang, Hua;
Affiliation
Uruguayan Center for Molecular Imaging (CUDIM) Montevideo Uruguay
Savio, Eduardo;
Affiliation
National Center for Nuclear Energy, Science and Technology (CNESTEN) Rabat Morocco
Bentaleb, Naoual;
Affiliation
University of Buenos Aires Buenos Aires Argentina
Zubillaga, Marcela;
Affiliation
University of Tennessee Knoxville USA
Chaple Gore, Ivis F.;
Affiliation
Nantes University Hospital - Nuclear Medicine Department Nantes France
Bourgeois, Mickaël;
Affiliation
Bhabha Atomic Research Centre & Homi Bhabha National Institute Mumbai India
Mukherjee, Archana;
Affiliation
Institute of Materials Science of Barcelona (ICMAB-CSIC) Barcelona Spain
Pellico, Juan;
ORCID
0000-0003-4846-1271
Affiliation
Institute of Radiopharmaceutical Cancer Research, Faculty of Chemistry and Food Chemistry, School of Science Helmholtz-Zentrum Dresden- Rossendorf (HZDR), Technical University Dresden (TUD) Dresden Germany
Kopka, Klaus

Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals. Main Body This selection of highlights provides commentary on 18 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © The Author(s) 2025

Use and reproduction: